If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCSLT.L Regulatory News (CSLT)

  • There is currently no data for CSLT

Rule 8.3- Cosalt PLC

10 Aug 2009 16:03

RNS Number : 1896X
David Ross
10 August 2009
Β 

ο»Ώ

Β  FORM 8.3

DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MOREΒ 

(Rule 8.3 ofΒ theΒ TakeoverΒ Code)

1. KEY INFORMATION

Name of person dealingΒ Β (Note 1)

David Ross

Company dealt in

Cosalt

Class of relevant security to which the dealings being disclosed relateΒ (Note 2)

Ordinary 1p

Date of dealing

05/08/09

2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE

(a) InterestsΒ and short positionsΒ (following dealing) in the class of relevant security dealt inΒ (Note 3)

Long

Short

Number (%)

Number (%)

(1) Relevant securitiesΒ 

3,989,296 15.1%

(2) DerivativesΒ (other than options)

(3)Β OptionsΒ and agreements to purchase/sell

Total

3,989,296 15.1%

(b) InterestsΒ and short positionsΒ in relevant securities of the company, other than theΒ classΒ dealt inΒ (Note 3)

Class of relevant security:

Long

Short

Number (%)

Number (%)

(1) Relevant securitiesΒ 

(2) DerivativesΒ (other than options)

(3)Β OptionsΒ and agreements to purchase/sell

Total

(c) Rights to subscribeΒ (Note 3)

Class of relevant security:

Details

Ordinary shares

Fitel Nominees LimitedΒ has agreed to subscribe forΒ 22,200,000Β new ordinary shares in the proposed firm placing by Cosalt. Should the Firm placing proceed as proposed thenΒ Fitel Nominees LimitedΒ Β would as a result of the firm placing be interested inΒ 26,189,296Β new ordinary shares representingΒ 6.47%Β ofΒ 404,403,397 being the total new ordinary shares

3. DEALINGSΒ (Note 4)

(a) Purchases and sales

Purchase/sale

Number of securities

Price per unitΒ (Note 5)

(b) Derivatives transactions (other than options)

Product name,Β 

e.g. CFD

Long/shortΒ (NoteΒ 6)

Number of securitiesΒ (Note 7)

Price per unitΒ (Note 5)

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

Product name,

e.g.Β callΒ option

Writing, selling, purchasing, varying etc.

Number of securitiesΒ to which the option relatesΒ (Note 7)

Exercise

priceΒ 

Type,Β e.g. American, European etc.

ExpiryΒ 

date

Option money

paid/receivedΒ per unitΒ (Note 5)Β 

(ii) Exercising

Product name,Β e.g.Β call option

Number of securitiesΒ 

Exercise priceΒ per unitΒ (Note 5)

(d) Other dealings (including new securities)Β (Note 4)

Nature of transactionΒ (Note 8)

Details

PriceΒ per unitΒ (if applicable)Β (Note 5)

Participation in Firm placing

See section 2.c above

5p

4. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form orΒ relating to the voting rights orΒ future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

Is a Supplemental Form 8 attached?Β (Note 9) YES/NO

Date of disclosure

10/08/09

Contact name

N Lamb

Telephone number

02072201673

If a connected EFM, name of offeree/offeror with which connected

If a connected EFM,Β state natureΒ of connectionΒ (NoteΒ 10)

Notes

The Notes on Form 8.3 can be viewed on the Takeover Panel's website atΒ www.thetakeoverpanel.org.uk

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
RETPMMATMMMBBML
Date   Source Headline
18th Sep 20087:00 amRNSInterim Management Statement
27th Aug 20082:22 pmRNSDirector/PDMR Shareholding
30th Jul 20087:00 amRNSCompletion of Acquisition
24th Jul 20081:26 pmRNSDirector/PDMR Shareholding
22nd Jul 20087:00 amRNSDirector/PDMR Shareholding
18th Jul 20081:58 pmRNSDirector's Dealings
17th Jul 20081:57 pmRNSHolding(s) in Company
14th Jul 20087:00 amRNSPlacing
30th Jun 200812:42 pmRNSInterim Dividend
26th Jun 20087:00 amRNSInterim Results
19th May 20087:04 amRNSAppointment of Chief Executiv
14th May 20087:00 amRNSDisposal and Acquisition
14th Apr 20087:00 amRNSChange of Adviser
27th Mar 20082:16 pmRNSTotal Voting Rights
27th Mar 20082:08 pmRNSAnnual Information Update
26th Mar 20087:45 amRNSRe Directorate
20th Mar 20081:01 pmRNSDirector's Dealings
20th Mar 20089:00 amRNSResult of AGM
19th Mar 20087:00 amRNSInterim Management Statement
20th Feb 20084:26 pmRNSDirector/PDMR Shareholding
30th Jan 20087:01 amRNSFinal Results
12th Dec 200710:56 amRNSTotal Voting Rights
20th Nov 20071:41 pmRNSDirector/PDMR Shareholding
20th Nov 20071:40 pmRNSHolding(s) in Company
1st Nov 200712:30 pmRNSDirector/PDMR Shareholding
30th Oct 20077:01 amRNSAppointment of Joint Broker
17th Oct 20074:04 pmRNSHolding(s) in Company
17th Oct 20073:49 pmRNSHolding(s) in Company
17th Oct 20073:47 pmRNSHolding(s) in Company
17th Oct 20072:09 pmRNSDirector/PDMR Shareholding
17th Oct 20072:00 pmRNSDirector/PDMR Shareholding
17th Oct 20071:54 pmRNSTotal Voting Rights
15th Oct 200711:14 amRNSDirector/PDMR Shareholding
12th Oct 20074:35 pmRNSCompletion of Acquisition
12th Oct 20073:33 pmRNSCompletion of Disposal
11th Oct 200712:14 pmRNSResult of EGM
11th Oct 200711:03 amRNSResult of EGM
9th Oct 20074:12 pmRNSPlacing & Open Offer Results
1st Oct 200712:57 pmRNSDirector/PDMR Shareholding
18th Sep 20077:01 amRNSNotice of EGM
14th Sep 20071:08 pmRNSDirector/PDMR Shareholding
13th Sep 20077:02 amRNSAcquisition
12th Jul 20074:35 pmRNSDirector/PDMR Shareholding
3rd Jul 20077:01 amRNSAcquisition
3rd Jul 20077:01 amRNSInterim Results
23rd May 20072:21 pmRNSHolding(s) in Company
3rd May 20079:17 amRNSDirector/PDMR Shareholding
20th Apr 20074:09 pmRNSDirector/PDMR Shareholding
19th Apr 20073:00 pmRNSTotal Voting Rights
17th Apr 200712:58 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.